SHL Medical’s climate targets officially approved by Science Based Targets initiative (SBTi)
The Science Based Targets initiative (SBTi) has approved SHL Medical’s near-term science-based emissions reduction target. The independent verification of SHL’s ambitious 2030 goals also acknowledges the company’s contribution to limiting global warming to 1.5°C. This underlines its dedication to remaining transparent and accountable throughout its entire sustainability journey.
SHL Medical, a world-leading provider of advanced drug delivery solutions, is proud to announce that its science-based targets to reduce overall greenhouse gas (GHG) emissions have been verified by the SBTi. With the official recognition to contributing to limit global warming to 1.5°C and therefore meeting the requirements of the Paris Agreement, the MedTech company with their sustainability strategy is working toward aligning its global operation towards a public and transparent commitment.
Confirmed Near-Term Targets
As part of SHL’s sustainability strategy,
- SHL Medical commits to reduce absolute direct (Scope 1) and indirect (scope 2) greenhouse gas emissions by 42% by 2030 from a 2022 base year.
- SHL Medical commits to reducing its indirect (scope 3) greenhouse gas emissions by at least 51.6% per Mio. units sold by 2030 from a 2022 base year.
Science-based targets provide a clearly defined pathway for companies to reduce GHG emissions, helping to prevent the impacts of climate change and future-proof businesses. Targets are considered science-based if they are in line with what the latest climate science deems necessary to meet the targets of the Paris Agreement – limiting global warming to 1.5°C above pre-industrial levels.
“The verification of our climate targets by the Science Based Targets initiative, an independent and highly respected body in this matter, underlines our commitment to remain transparent and accountable for our sustainability goals and the entire journey that we embark on with our sustainability strategy 2030”, says Ulrich Faessler, CEO of SHL Medical.
About the Science Based Target initiative (SBTi)
The Science Based Targets initiative (SBTi) is a global body enabling businesses to set ambitious emissions reductions targets in line with the latest climate science. It is focused on accelerating companies across the world to halve emissions before 2030 and achieve net-zero emissions before 2050.
The initiative is a collaboration between CDP, the United Nations Global Compact, World Resources Institute (WRI) and the World Wide Fund for Nature (WWF) and one of the We Mean Business Coalition commitments. The SBTi defines and promotes best practice in science-based target setting, offers resources and guidance to reduce barriers to adoption, and independently assesses and approves companies’ targets. www.sciencebasedtargets.com
